Single Use Bioprocessing Market is predicted to reach USD 46.56 billion at a CAGR of 20.80% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Single Use Bioprocessing Market”.

The single-use bioprocessing market is estimated to register a CAGR of 20.80% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the Single-Use Bioprocessing market— Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Pall Corporation, Corning Incorporated, Eppendorf AG, General Electric Company (GE Healthcare), Lonza, Rentschler Biopharma SE, JM BioConnect, Meissner Filtration Products, Inc., Infors AG, Boehringer Ingelheim GmbH, Entegris, Inc., and PBS Biotech Inc.

Market Highlights

The single-use bioprocessing market is accounted to register a CAGR of 20.80% during the forecast period and is estimated to reach USD 46.56 billion by 2032.

The need for biopharmaceuticals is projected to rise as the global aged population expands. This is due to the increased prevalence of age-related illnesses among the world's elderly population. Companies are increasingly favoring single-use bioprocessing systems to meet the rising demand for biopharmaceuticals. These systems improve process efficiency and reduce the expenses associated with complex steps like cleaning, sterilization, and maintenance of steel-based bioreactor systems. The biopharmaceutical industry makes extensive use of single-use bioprocessing technologies for tasks like filtration, mixing, purification, upstream expression, storage, and separation. As a result, the rising need for biopharmaceuticals is one of the main factors fueling the expansion of the single-use bioprocessing sector. However, there are significant issues with how this alternative technology deals with solid waste. These products cannot be recycled because it would take too much time and energy to disassemble them into usable parts. Therefore, it is not feasible to recycle the majority of single-use systems and the factors that make them up.

Segment Analysis

The single-use bioprocessing market has been segmented based on product, application, end-user, and workflow.

On the basis of product, the market is segmented into filtration assemblies, disposable bioreactors, disposable mixers, media bags & containers, and others. The media bags & containers segment was attributed to holding the largest market share in 2022 because media bag and container use in the biopharmaceutical business reduces capital expenditure, waste generation, and operational expenses.

Based on application, the single-use bioprocessing market has been segmented into filtration, purification, cell culture, and others. The filtration segment was expected to hold market dominance in 2022 due to single-use bioprocessing systems are gaining popularity for use in filtration since they filter even when used in huge quantities. It can be ultra-filtered, utilized to smooth out biomolecules and reduce bio-burden.

Based on end-users, the single-use bioprocessing market has been segmented into biopharmaceutical manufacturers, clinical & academic research institutes, and others. The biopharmaceutical manufacturers segment was expected to hold market dominance in 2022 because high expansion can be attributed to a number of factors, including the increasing commercial success of biologics and the consequent rise in contract manufacturing services.

Based on workflow, the single-use bioprocessing market has been segmented into upstream, fermentation, and downstream. The upstream segment was expected to hold the top market share in 2022 because biopharmaceutical companies have been able to standardize processes, increase output, and reduce costs, thanks to the improvements made to this workflow during the past year. Biopharmaceutical companies now have access to a more efficient and cost-effective method because of developments in upstream single-use bioprocessing.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Single-use Bioprocessing Market Research Report

Regional Analysis

The single-use bioprocessing market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America consists of the US and Canada. The European Single Use Bioprocessing market comprises Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Single Use Bioprocessing market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia-Pacific. The Rest of the World Single Use Bioprocessing market comprises the Middle East, Africa, and Latin America.

The North American regional sector maintained the largest market share for single-use bioprocessing. This increase is attributed to rising demand for biopharmaceuticals in light of aging populations and a greater emphasis on high-quality healthcare; bio-manufacturers are expanding their facilities. Single-use bioprocessing systems have seen a rise in popularity due to their convenience, low price, and the advent of new technology in this region.

Moreover, the European market has been persistently growing over the forecast period. The demand for single-use bioprocessing is driven by the growing healthcare infrastructure, vast numbers of manufacturers, rising disposable product sales, rising healthcare costs, an already-developed healthcare infrastructure, and positive reimbursement policies in healthcare all contribute to the expansion of this industry.

Additionally, due to the high demand, there is increased usage of single-usage gadgets. The pharmaceutical and laboratory equipment markets have expanded quickly in Asia and the Pacific, creating promising new prospects for single-use bioprocessing goods. Asia Pacific is anticipated to experience the quickest growth over the forecast period.

Furthermore, the Rest of the World's single-use bioprocessing market is divided into the Middle East, Africa, and Latin America. This growth is attributed to the region's large-scale production units, which are driving the development of the single-use bioprocessing market. The single-use bioprocessing industry in the area is increasing at an exceptionally rapid clip due to the abundance of contract producers and the rising prevalence of disposables among them.

Key Findings of the Study

• The single-use bioprocessing market is expected to reach USD 46.56 billion by 2032, at a CAGR of 20.80% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market because of the high demand for products used in bioprocessing, such as laboratory filtration systems and membrane-based microbial analysis.


• Based on product, the media bags & containers segment was attributed to holding the largest market in 2022.


• Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Pall Corporation, Corning Incorporated, Eppendorf AG, General Electric Company (GE Healthcare), Lonza, Rentschler Biopharma SE, JM BioConnect, Meissner Filtration Products, Inc., Infors AG, Boehringer Ingelheim GmbH, Entegris, Inc., and PBS Biotech Inc.